Read more
Zusatztext I wholeheartedly recommend this handbook to clinicians who prescribe products of the biotechnology industry to treat chronic inflammatory diseases. Informationen zum Autor Dr. Bruce Kirkham is currently Clinical Lead in Rheumatology/Lupus at Guy's & St. Thomas' Hospital Trust, London. His clinical research interests focus on optimising the use of drugs for the treatment of inflammatory arthritis.Arthur Kavanaugh, MD, is a Professor of Medicine at the University of California, San Diego (UCSD) School of Medicine and Director of the Center for Innovative Therapy in the UCSD Division of Rheumatology, Allergy, and Immunology. He is also a fellow of the American Academy of Allergy, Asthma, and Immunology (AAAAI), and the American College of Rheumatology (ACR).Scott Plevy, MD, is an Associate Professor of Medicine, Microbiology and Immunology at the University of North Carolina School of Medicine, Division of Gastroenterology and Hepatology. He is the Director of the University of North Carolina FOCIS Center of Excellence.Jonathan Barker has been Academic Head of St John's Institute of Dermatology since 2002. He is co-director of the Skin Therapy Research Unit and head of the Psoriasis Service at St John's Institute of Dermatology. His research interests focus on inflammatory skin diseases, particularly psoriasis. Klappentext This book provides a comprehensive distillation of the clinical experience with Tumor Necrosis Factor (TNF) blocking therapy drugs combined with the diverse available databases to provide practical information about the use of these drugs in daily practice. Zusammenfassung This book provides a comprehensive distillation of the clinical experience with Tumor Necrosis Factor (TNF) blocking therapy drugs combined with the diverse available databases to provide practical information about the use of these drugs in daily practice.
